Mikehl S. Hafner

914 citations
10 papers · 750 indexed · h-index 8

Mikehl S. Hafner

10 papers receiving 736 citations

Peers

Mikehl S. Hafner
Comparison fields: 5 of 72
  • Molecular Medicine 132
  • Immunology 254
  • Dermatology 104
  • Pharmacology 75
  • Pathology and Forensic Medicine 134
Replace Kirit Pindolia with:
Kirit Pindolia United States
Sühendan Ekmekçioğlu United States
Wenqin Xiao China
Yu‐Chang Liu Taiwan
Suchismita Mohanty India
Okkyung Rho United States
Madhavi Sekharam United States
Ming‐Chung Jiang Taiwan
Milena Pervan United States
Mikehl S. Hafner relative to Kirit Pindolia United States Kirit Pindolia's profile →
Citations per field
00.5×8.7×
Kirit Pindolia · 1×
Citations per year

Countries citing papers authored by Mikehl S. Hafner

Since Specialization
Citations

This map shows the geographic impact of Mikehl S. Hafner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikehl S. Hafner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikehl S. Hafner more than expected).

Fields of papers citing papers by Mikehl S. Hafner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikehl S. Hafner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikehl S. Hafner. The network helps show where Mikehl S. Hafner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mikehl S. Hafner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mikehl S. Hafner Line = papers co-authored together Mikehl S. Hafner links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 2013103
2 20103
3 200871
4 200793
5 200561
6 200448
7
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
2004125
8 2004111
9 2002133
10 19892

About Mikehl S. Hafner

Mikehl S. Hafner is a scholar working on Molecular Medicine, Dermatology and Immunology, having authored 10 papers that have together received 750 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (3 papers), Cutaneous lymphoproliferative disorders research (3 papers), NF-κB Signaling Pathways (2 papers), Curcumin's Biomedical Applications (2 papers), T-cell and Retrovirus Studies (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Molecular Medicine (132 citations), Immunology (254 citations) and Dermatology (104 citations). Mikehl S. Hafner has collaborated with scholars based in United States and Spain. Frequent co-authors include Henry K. Wong, Heather M. Gibson, Raymond Novak, Kimberley J. Woodcroft, Adam J. Wilson, Barbara Aufiero, George Divine, Scott A. Dulchavsky, Robert Chapman and Xiaohua Gao. Their work appears in journals such as The Journal of Immunology, Hepatology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026